Price Notification

(Published in Part II, Section 3, Sub Section (ii) of the
Gazette of India Extraordinary, dated the 30th April, 2009)

Government of India
Ministry of Chemicals and Fertilizers
(National Pharmaceuticals Pricing Authority)

                                                                New Delhi, the 30th April, 2009

ORDER

S.O.1125(E)  - In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Aventis Pharma Ltd.

TABLE

Sl. No. Name of the Formulation Pack Size Existing Retail Price (Rs.) Retail Price without Excise Duty Sales Tax /VAT and Local Tax, if any (Rs.) Equivalent MRP*(inclusive of all taxes)(Rs.)
(1) (2) (3) (4) (5) (6)
1 Lantus 100 IU / ML Cartridge
Each ml contians
Monocomponent Insulin
Glargine - 100 IU
Batch No. 40U 547 / Qty 3725 Catridges
Batch No. 40U 561 / Qty. 25225 Cartridges
Batch No. 40U 566 / Qty. 16575 Cartridges
Batch No. 40U 577 / Qty. 8475 Cartridges
3ml Cartridge 481.35 543.12 564.84
2 Lantus 100 IU / ML Solostar
Each ml contians
Monocomponent Insulin
Glargine - 100 IU
Batch No. 40U148 / Qty 69600 Catridges
3ml Cartridge 855.60 855.60 889.82

*Subject to actual payment of Government levies/taxes, as applicable.

NOTE :

(a)        The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(b)        The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.

(c)        For different packing material used or, different drug delivery systems or any other special features/forms claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.

(d)        The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.

(e)        These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.

(f)        These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.

(g)        The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.

PN/108/2009/F                                

F. No. 8(17)/2009/D.P./NPPA-Div.II

(RAJIV WADHAWAN)
Deputy Director
National Pharmaceutical Pricing Authority

                                                         


Top of the Page | Home